Author:
Brantley Kristen D,Douglas Teresa D,Singh Rani H
Funder
BioMarin Pharmaceutical
Clinical and Translational Science Award program, National Institutes of Health
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Genetics (clinical),General Medicine
Reference26 articles.
1. Hood A, Grange DK, Christ SE, et al. Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria. Mol Genet Metab. 2014;111:445–51.
2. Muntau AC, Roschinger W, Habich M, et al. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N Engl J Med. 2002;347:2122–32.
3. Keil S, Anjema K, van Spronsen FJ, et al. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study. Pediatrics. 2013;131:e1881–8.
4. Vockley J, Andersson HC, Antshel KM, et al. Phenylalanine hydroxylase deficiency: diagnosis and management guideline. Genet Med. 2014;16:188–200.
5. Food and Drug Administration. News Release: FDA approves Kuvan for treatment of phenylketonuria (PKU). 13 Dec 2007.
https://www.sec.gov/Archives/edgar/data/1048477/000119312507264738/dex991.htm
.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献